Predicting the chemotherapeutic efficacy in acute leukemia by cell apoptosis in vivo 24 hours after chemotherapy
Zhou Keshu
Abstract
Zhou Keshu
Abstract
Objective:To investigate the relationship between apoptosis in vivo and chemotherapy in acute leukemia in order to provide an early index for the prediction of clinical chemotherapy reponse.Method:The in vivo apoptosis before and 24 hours after chemotherapy was detected with flow cytometer by an early apoptosis marker Annexin V.Result:The apoptosis of leukemic cells before chemotherapy was ( 5.74± 2.47)% and obviously increased 24 hours after chemotherapy ( 9.77± 3.54)%,P 0.001). 12 patients achieved complete remission (CR), 1 partial remission (PR) and 12 non-remission (NR). CR and PR patients were defined as efficient group and NR patients as failure group. The apoptosis rate of efficient group increased ( 5.91± 3.48)% 24 hours after chemotherapy ( 11.45± 3.09)%; the apoptosis rate 24 hours after chemotherapy of failure group was ( 8.15± 3.66)%,and apoptosis cells increased ( 2.28± 3.58)%. Apoptosis induced by chemotherapeutics was significantly increased in the efficient group compared with the failure group (P 0.05). Its specificity and sensitivity were 83.3% and 84.6% respectively.Conclusion:In vivo aoptosis detected by flow cytometry Annexin V assay is a sensitive and early index to predict clinical efficacy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the relationship between apoptosis in vivo and chemotherapy in acute leukemia in order to provide an early index for the prediction of clinical chemotherapy reponse.Method:The in vivo apoptosis before and 24 hours after chemotherapy was detected with flow cytometer by an early apoptosis marker Annexin V.Result:The apoptosis of leukemic cells before chemotherapy was ( 5.74± 2.47)% and obviously increased 24 hours after chemotherapy ( 9.77± 3.54)%,P 0.001). 12 patients achieved complete remission (CR), 1 partial remission (PR) and 12 non-remission (NR). CR and PR patients were defined as efficient group and NR patients as failure group. The apoptosis rate of efficient group increased ( 5.91± 3.48)% 24 hours after chemotherapy ( 11.45± 3.09)%; the apoptosis rate 24 hours after chemotherapy of failure group was ( 8.15± 3.66)%,and apoptosis cells increased ( 2.28± 3.58)%. Apoptosis induced by chemotherapeutics was significantly increased in the efficient group compared with the failure group (P 0.05). Its specificity and sensitivity were 83.3% and 84.6% respectively.Conclusion:In vivo aoptosis detected by flow cytometry Annexin V assay is a sensitive and early index to predict clinical efficacy.
Key concepts: Apoptosis, Chemotherapy, In vivo, Annexin, Flow cytometry, Leukemia, Acute leukemia, Medicine